Abstract:Background: Existing guidelines recommend a triple immunosuppressive regimen with calcineurin inhibitors, antimetabolites, and corticosteroids for postoperative immunosuppression in renal transplant patients. However, few studies have compared cyclosporine and tacrolimus for long-term outcomes. In this study, the meta-analysis was used to compare long-term outcomes in renal transplant patients to evaluate the use of cyclosporine vs. tacrolimus. The pros and cons of suppression programs have been analyzed. Methods: Cyclosporine, tacrolimus, and kidney transplantation, were used as search terms to retrieve relevant publications in PubMed, Embase, and The Cochrane library. Two independent researchers screened and evaluated the relevant results of each search using the RevMan5.4 program to make relevant charts for the meta-analysis. Odds ratios (OR) and 95% confidence intervals (CI) were used to report dichotomous variables, while mean differences (MD) and 95% confidence intervals (CI) were used to report continuous variables. The study took tacrolimus- and cyclosporine-based maintenance immunosuppression as experimental and control groups, respectively. The graft and patient survival outcomes were followed for 5 or more years. Results: Overall, thirteen studies were included in the meta-analysis, including nine randomized controlled trials and four non-randomized controlled trials. Compared with the cyclosporine group, the incidence of rejection, drug conversion, and dyslipidemia were significantly lower in the tacrolimus group. Furthermore, there was higher glomerular filtration rates and graft survival rates in the tacrolimus group than in the cyclosporine group. In contrast, there were no significant differences between the two groups in terms of patient survival, incidence of infection, hypertension and new tumors. However, the use of tacrolimus was associated with a high risk of a new onset of diabetes. Conclusion: The meta-analysis showed that, compared with cyclosporine, tacrolimus increases the risk of a new-onset diabetes. However, tacrolimus had higher graft survival rate and better creatinine clearance than cyclosporine.

The effect of calcineurin inhibitors on endothelial function in renal transplant recipients

Endothelial dysfunction in renal transplant patients is closely related to serum cyclosporine levels

Does the endothelial function change in renal transplant patients with longer duration of exposure and with higher cumulative doses of cyclosporine?

Effect of Switch from Cyclosporine to FK506 on Renal Graft Outcome in Patients after Initial Acute Rejection

Cyclosporine A and Tacrolimus Induce Functional Impairment and Inflammatory Reactions in Endothelial Progenitor Cells

Effect of Kaempferol on Tacrolimus-Induced Nephrotoxicity and Calcineurin B1 Expression Level in Animal Model

Reduced-Dose Cyclosporine with Mycophenolate Mofetil and Prednisone Significantly Improves the Long-Term Glomerular Filtration Rate and Graft Survival

Calcineurin inhibitors' impact on cardiovascular and renal function, a descriptive study in lung transplant recipients from the North of Spain

Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation

Clinical Study on the Use of FK506 after Renal Transplantation

Clinical study of tacrolimus in postoperative treatment of patients with renal transplantation for diabetic end-stage renal disease]

Management of Calcineurin Inhibitors-Related Chronic Kidney Disease in Cardiac Transplantation

COMPARISON OF THE EFFECTS ON SERUM LIPIDS BETWEEN FK506 AND CYCLOSPLRIN A IN RENAL AL.LOGRAFF RECIPIENTS

Pulse wave analysis to assess vascular compliance changes in stable renal transplant recipients

[Application of Tacrolimus and Cyclosporine A in HBV-carrying Renal Transplant Recipients].

Long-term clinicopathological impact of calcineurin inhibitor cessation without specific cytoreductive induction in kidney transplantation

Using Calcineurin Inhibitor in donor preconditioning reduce ischemia-reperfusion injury in rat renel transplantation and the mechanisms

Effects of Immunosuppressants on CD+ CD25+ Regulatory T Cells in Human Renal Transplant Recipients

Application of Urine Micro-Protein Determination for Evaluating Renal Toxicity Lesionly by Calcineurin Inhibitor in Patient with Liver Transplantation

Immunosuppression with cyclosporine versus tacrolimus shows distinctive nephrotoxicity profiles within renal compartments

Systematic review and meta-analysis of calcineurin inhibitors on long-term prognosis of renal transplant patients